Spyglass Ophthalmics Stock

www.spyglasspharma.comHealthcare / Medical DevicesFounded: 2019

Spyglass Pharma is a drug delivery and ophthalmic platform for patients with eye problems. With a mission to treat glaucoma and cataract surgery patients, Spyglass Pharma is using drug innovation technology to improve the standard of eye care through consistent drug design and delivery. Spyglass Pharma was founded by Glenn Sussman in 2019 and is headquartered in Los Angeles, CA.

Register To Buy and Sell Shares

For more details on financing and valuation for Spyglass Ophthalmics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Spyglass Ophthalmics’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Spyglass Ophthalmics.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Register

Animation displayed is not current and securities are shown for illustrative purposes only.

Team

Management Team

Malik Kahook MD
Co-Founder, President & Executive Chairman
James Dennewill
Chief Operating Officer
Glenn Sussman
Co-Founder & Chief Technology Officer
Patrick Mooney
Chief Executive Officer, Vice President of Research and Development & TalentWell Marketing Specialist

Board Members

Ali Behbahani MD
New Enterprise Associates

Frequently Asked Questions About Spyglass Ophthalmics’ Stock

plusminus
Can you buy Spyglass Ophthalmics’ stock?
Spyglass Ophthalmics is not publicly traded on NYSE or NASDAQ in the U.S. To buy Spyglass Ophthalmics’ stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
plusminus
Can you sell Spyglass Ophthalmics’ stock?
Yes, you can sell stock of a private company like Spyglass Ophthalmics. Forge can help you sell your Spyglass Ophthalmics stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
plusminus
What is Spyglass Ophthalmics’ stock price?
Spyglass Ophthalmics is a privately held company and therefore does not have a public stock price. However, you may access Spyglass Ophthalmics’ private market stock price with Forge Data.
plusminus
What is Spyglass Ophthalmics’ stock ticker symbol?
Spyglass Ophthalmics does not have an official ticker symbol because this company is not currently publicly traded.
plusminus
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

SpyGlass Pharma Closes $90M Series C
SpyGlass Pharma, an Aliso Viejo, CA-based ophthalmic therapeutics company, raised $90M in Series C funding. The round was led by RA Capital Management alongside existing investors New Enterprise Associates and Vensana Capital, as well as new investors Samsara BioCapital and Vertex Ventures HC.
Updated on: May 23, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.